StonvexLoading…
StonvexStonvexStonvexCore line items from ASLE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $335.29M | $345.07M | $334.50M | $408.54M |
Operating Income | $15.79M | $9.74M | $-10.77M | $55.05M |
Net Income | $8.57M | $5.85M | $-5.56M | $43.86M |
EPS (Diluted) | $0.18 | $0.11 | $-0.15 | $0.83 |
Total Assets | $640.47M | $604.72M | $553.94M | $531.58M |
Total Liabilities | $216.04M | $149.10M | $108.92M | $86.60M |
Cash & Equivalents | $4.38M | $4.70M | $5.87M | $147.19M |
Free Cash Flow OCF − CapEx | $-29.05M | $-2.87M | $-185.51M | $-8.57M |
Shares Outstanding | 47.22M | 53.25M | 52.95M | 51.19M |